Inside Duke Medicine
Media Spotlight: WRAL features Freedland’s prostate cancer research
posted July 7th, 2010
Stephen Freedland, M.D., a urologist, talks about his research that shows statin medications benefit men who have had prostate cancer surgery.
“And what we saw was that the men on statins had about a 30 percent lower risk that the cancer would come back,” he said in the video.